PubMed

Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes.

Nauck MA, Baller B, Meier JJ.

Diabetes. 2004 Dec;53 Suppl 3:S190-6. Review.PMID: 15561910 [PubMed - indexed for MEDLINE]Related articlesFree article

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.

Nauck MA, El-Ouaghlidi A, Gabrys B, Hücking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ.

Regul Pept. 2004 Nov 15;122(3):209-17.PMID: 15491793 [PubMed - indexed for MEDLINE]Related articles

Incretins, insulin secretion and Type 2 diabetes mellitus.

Vilsbøll T, Holst JJ.

Diabetologia. 2004 Mar;47(3):357-66. Epub 2004 Feb 13. Review.PMID: 14968296 [PubMed - indexed for MEDLINE]Related articles

Overview of incretin hormones.

Efendic S, Portwood N.

Horm Metab Res. 2004 Nov-Dec;36(11-12):742-6. Review.PMID: 15655702 [PubMed - indexed for MEDLINE]Related articles

Glucagon-like peptide-1 and control of insulin secretion.

Thorens B.

Diabete Metab. 1995 Dec;21(5):311-8. Review.PMID: 8586147 [PubMed - indexed for MEDLINE]Related articles

GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.

Hansotia T, Drucker DJ.

Regul Pept. 2005 Jun 15;128(2):125-34. Review.PMID: 15780432 [PubMed - indexed for MEDLINE]Related articles

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.

Vilsbøll T, Krarup T, Madsbad S, Holst JJ.

Regul Pept. 2003 Jul 15;114(2-3):115-21.PMID: 12832099 [PubMed - indexed for MEDLINE]Related articles

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W.

J Clin Invest. 1993 Jan;91(1):301-7.PMID: 8423228 [PubMed - indexed for MEDLINE]Related articlesFree article

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.

Elahi D, McAloon-Dyke M, Fukagawa NK, Meneilly GS, Sclater AL, Minaker KL, Habener JF, Andersen DK.

Regul Pept. 1994 Apr 14;51(1):63-74.PMID: 8036284 [PubMed - indexed for MEDLINE]Related articles

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.

Creutzfeldt W.

Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S288-303. Review.PMID: 11460578 [PubMed - indexed for MEDLINE]Related articles

Incretin hormones--an update.

Holst JJ, Orskov C.

Scand J Clin Lab Invest Suppl. 2001;234:75-85. Review.PMID: 11713984 [PubMed - indexed for MEDLINE]Related articles

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.

Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.

J Clin Endocrinol Metab. 1993 Apr;76(4):912-7.PMID: 8473405 [PubMed - indexed for MEDLINE]Related articles

The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.

Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.

J Clin Endocrinol Metab. 2003 Oct;88(10):4897-903.PMID: 14557471 [PubMed - indexed for MEDLINE]Related articlesFree article

Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?

Holst JJ.

BioDrugs. 2002;16(3):175-81. Review.PMID: 12102645 [PubMed - indexed for MEDLINE]Related articles

Gastric inhibitory polypeptide: the neglected incretin revisited.

Meier JJ, Nauck MA, Schmidt WE, Gallwitz B.

Regul Pept. 2002 Jul 15;107(1-3):1-13. Review.PMID: 12137960 [PubMed - indexed for MEDLINE]Related articles

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.

Holst JJ, Gromada J.

Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E199-206. Review.PMID: 15271645 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1).

Ranganath L, Schaper F, Gama R, Morgan L, Wright J, Teale D, Marks V.

Diabetes Metab Res Rev. 1999 Nov-Dec;15(6):390-4.PMID: 10634963 [PubMed - indexed for MEDLINE]Related articles

Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.

Schou JH, Pilgaard K, Vilsbøll T, Jensen CB, Deacon CF, Holst JJ, Vølund A, Madsbad S, Vaag AA.

J Clin Endocrinol Metab. 2005 Aug;90(8):4912-9. Epub 2005 May 17.PMID: 15899957 [PubMed - indexed for MEDLINE]Related articlesFree article

[Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus]

Vilsbøll T, Knop FK.

Ugeskr Laeger. 2007 May 28;169(22):2101-5. Review. Danish. PMID: 17553392 [PubMed - indexed for MEDLINE]Related articles